In 2020, the COVID-19 pandemic exacerbated barriers to care and treatment for individuals experiencing opioid use disorder. Experts estimate a record-setting 90,000 people died of a drug overdose in ...
In the Public Health Review podcast debut, host Robert Johnson speaks with public health officials from Alaska, Kentucky, and West Virginia about the ongoing opioid epidemic in the U.S. and its ...
The second half of Public Health Review's story on the opioid epidemic explores how coalitions in Kentucky are driving prevention efforts, what public health practitioners in West Virginia are ...
This episode highlights COVID-19’s impact on overdose-related deaths during the postpartum period, also known as the fourth trimester. There has been a significant increase in postpartum ...
In this episode, we explore Pennsylvania’s multi-pronged approach to addressing the opioid epidemic in the state and efforts to expand access to Medication Assisted Treatment.
This episode discusses why there needs to be a comprehensive response in public health surveillance, in particular around the opioid epidemic. After all, without thorough data, it’s tough for ...
This conversation was recorded in May 2020, but felt the lessons and takeaways are still very relevant as we are finally starting to emerge from the COVID-19 pandemic. The rates of depression, ...
In February 2019, ASTHO surveyed its members to understand how data is being utilized to address these harms in their jurisdictions. This brief summarizes the results of this survey and highlights ...
Opioid and substance use disorders (SUD) continue to affect families beyond pregnancy; in 2017, about one in eight U.S. children lived in a household where at least one parent had a SUD in the prior ...
Initial estimates from 2020 suggest that annual drug overdose deaths in the United States reached a record high of 93,000. Fortunately EMS strategies are being put in place to combat this nation-wide ...
This report highlights six public health approaches for addressing the rising incidence of substance use disorder and neonatal abstinence syndrome and draws out the critical role that state health ...
This brief outlines some of the barriers that pregnant and postpartum women with opioid use disorder face, as well as examples of state legislation passed to address recovery program implementation, ...
State and territorial health agencies continue to be challenged by the opioid epidemic, which has been exacerbated by the COVID-19 pandemic. Addressing the opioid crisis requires a robust public ...
COVID-19 has elevated our nation’s stress level. When not managed properly (or without any buffers like social support) stress is associated with increased depression and anxiety. Because COVID-19 ...
With data showing the number of the opioid overdose deaths escalated during the COVID-19 pandemic, access to naloxone, a medication that can reverse an opioid overdose, continues to be an important ...
The opioid crisis continues to claim the lives of thousands across the United States and has cost the economy billions in health care, mortality, and criminal justice costs. In 2018, it’s estimated ...
With many of the state and territorial legislatures reconvening over the next few weeks, we can look forward to new (and not-so-new) legislation start to crop up that will impact public health. To ...
This brief describes how the New Mexico Department of Health has enhanced its harm reduction program to provide an evidence-based comprehensive care model to support the health of people who use ...
This brief discusses the difficulty of maintaining compassion and empathy during public health crises, which ultimately leads to a phenomenon called compassion fatigue.
Across the nation, public health agencies have mounted herculean efforts to stem the COVID-19 pandemic while addressing a pre-existing HIV epidemic and an opioid crisis that is serving as a source ...